Silence Therapeutics GAAP EPS of -$0.09 beats by $0.08
What it means
- What to watch: The headline hangs on one number ($0.09) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $SLN +0.05% in the latest session.
- Timing: It came out pre-market, so the next session was the first that could react.
Where the stock stands
$SLN last traded at $19.67, +0.05% on the session. That puts it 0.1% shy of its 52-week high of $19.69 and 369% clear of its low of $4.19 — within a tenth of its 52-week high. Over the year it has ranged 370% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $SLN page.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$SLN earnings in 12 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
For the receipts, the $SLN page has the full chart, the filings and the valuation model these figures come from. Comparing how two or three outlets frame the same story is the fastest way to separate the facts from the angle. And Wook AI, up top, will happily do the math — how far $SLN sits from its high, or how this week's coverage stacks up.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “beat” in the wording, with nothing on the bearish side to offset it. It was matched to $SLN. It carried $0.09 and $0.08, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 10, 2026. $SLN has moved +27.48% ($15.43 to $19.67). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.